Benzaclin, Carac and Xyzal

Quote

Anonymous

Guest
Any info about promoting these 3 products would be greatly appreciated. I know Benzaclin went generic, Xyzal is about to (in an overcrowded antihistamine market anyhow) and Carac has shown little growth. Insight would be appreciated, considering offer on the table.
 






reps still make 7-10k a qtr, good environment, uncertain future, dermik reps who are left are highly experienced and respected, just look at how they have held a generic at bay, if sanofi adds to the portfolio(which it has the money to do) then its a tremendous place. many of the dermik reps are sitting on a pile of money from their years later, three simultaneous pension plans, 4-5 wks vacation, off the charts benefits. Risky to come here for the fact that dermatology is in limbo, good luck.
 












Top Bottom
Back
Quote